GlycoMimetics, Inc. (GLYC) earnings
Quarterly and annual GLYC reports and results, each read against the price at its own news timestamp. Back to the GLYC overview →
7 measured GLYC earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q GLYCOMIMETICS INC For: Mar 31 | SEC filing · Form 10-Q | +2.89% | +7.76% | |
| Form 10-K GLYCOMIMETICS INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q GLYCOMIMETICS INC For: Sep 30 | SEC filing · Form 10-Q | +6.42% | +4.69% | |
| Form 10-Q GLYCOMIMETICS INC For: Jun 30 | SEC filing · Form 10-Q | -2.78% | +0.00% | |
| Form 10-Q GLYCOMIMETICS INC For: Mar 31 | SEC filing · Form 10-Q | -3.39% | -4.79% | |
| GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024 | Press release | +0.00% | -5.00% | |
| Form 10-K GLYCOMIMETICS INC For: Dec 31 | SEC filing · Form 10-K | +1.72% | +9.28% |
Keep exploring
More GLYC: analyst actions → · SEC filings → · GLYC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
| Oramed Pharmaceuticals Inc. (ORMP) | 145 | +0.69% | 69% |
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.